Figure 1From: Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance3-D waterfall plot. Best response by RECIST, of ten patients with BRAF-positive melanoma. Time to treatment failure in months is represented by solid lines and the arrow indicates that the patient was still on study when the data was censored.Back to article page